Literature DB >> 26617904

Association between matrix metalloproteinase gene polymorphisms and development of ischemic stroke.

Yunhua Hao1, Shihong Tian2, Min Sun3, Yuanjian Zhu4, Zhiyu Nie1, Shujuan Yang5.   

Abstract

We investigated the association between MMP2 rs243865, MMP3 rs3025058 and MMP9 rs3918242 polymorphisms and development of ischemic stroke in a Chinese population. Between January 2012 and May 2014, a total of 317 patients with ischemic stroke and 317 health control subjects were enrolled into our study. The MMP2 rs243865, MMP3 rs3025058 and MMP9 rs3918242 polymorphisms were analyzed using polymerase chain reaction (PCR) coupled with restriction fragment length polymorphism (RFLP). By multivariate logistic regression analysis, we found that individuals carrying with the CC genotype and the TC+CC genotype of MMP9 rs3918242 were associated with a significantly increased risk of ischemic stroke when compared with the TT genotype, and the ORs (95% CI) was 5.47 (2.64-12.38) and 1.55 (1.08-2.24), respectively. The TC+CC genotype of MMP9 rs3918242 was associated with an elevated risk of ischemic stroke in tobacco smokers, and the OR (95% CI) was 2.03 (1.11-3.74). In conclusion, our study suggests that MMP9 rs3918242 polymorphism is correlated with an elevated risk of ischemic stroke, and this gene polymorphism has interaction with tobacco smoking in the risk of ischemic stroke.

Entities:  

Keywords:  Matrix metalloproteinases; ischemic stroke; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26617904      PMCID: PMC4637720     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

1.  Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1.

Authors:  B Zhang; A Henney; P Eriksson; A Hamsten; H Watkins; S Ye
Journal:  Hum Genet       Date:  1999-11       Impact factor: 4.132

Review 2.  Identifying the carotid 'high risk' plaque: is it still a riddle wrapped up in an enigma?

Authors:  J Golledge; D-A Siew
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-11-05       Impact factor: 7.069

3.  Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Larry B Goldstein; Cheryl D Bushnell; Robert J Adams; Lawrence J Appel; Lynne T Braun; Seemant Chaturvedi; Mark A Creager; Antonio Culebras; Robert H Eckel; Robert G Hart; Judith A Hinchey; Virginia J Howard; Edward C Jauch; Steven R Levine; James F Meschia; Wesley S Moore; J V Ian Nixon; Thomas A Pearson
Journal:  Stroke       Date:  2010-12-02       Impact factor: 7.914

4.  Intra-arterial bone marrow mononuclear cell transplantation correlates with GM-CSF, PDGF-BB, and MMP-2 serum levels in stroke patients: results from a clinical trial.

Authors:  Francisco Moniche; Joan Montaner; Jose-Ramon Gonzalez-Marcos; Magdalena Carmona; Pilar Piñero; Ildefonso Espigado; Aurelio Cayuela; Irene Escudero; Francisco-Javier de la Torre-Laviana; Cristina Boada; Anna Rosell; Antonio Mayol; Maria-Dolores Jimenez; Alberto Gil-Peralta; Alejandro Gonzalez
Journal:  Cell Transplant       Date:  2014-10-20       Impact factor: 4.064

5.  [Association of MMP9 gene -1562 C/T polymorphism with myocardial infarction in Uighur population of Xinjiang].

Authors:  Lei WANG; Yi-tong MA; Xiang XIE; Yi-ning YANG; Zhen-yan FU; Fen LIU; Xiao-mei LI; Bang-dang CHEN
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2011-04

6.  Meta-analysis of MMP9-562C/T and the risk of coronary heart disease.

Authors:  Junyan Li; Hao Lu; Feng Tao; Hua Zhou; Guoyying Feng; Lin He; Ligang Zhou
Journal:  Cardiology       Date:  2013-01-15       Impact factor: 1.869

7.  Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes.

Authors:  Marc Fatar; Mark Stroick; Michael Steffens; Eva Senn; Bjoern Reuter; Simone Bukow; Martin Griebe; Angelika Alonso; Peter Lichtner; Peter Bugert; Thomas Meitinger; Thomas F Wienker; Michael G Hennerici
Journal:  Cerebrovasc Dis       Date:  2008-06-17       Impact factor: 2.762

8.  Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.

Authors:  Robert C Kaplan; Nicholas L Smith; Stanley Zucker; Susan R Heckbert; Kenneth Rice; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2008-03-14       Impact factor: 5.162

9.  Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke.

Authors:  Helena Manso; Tiago Krug; João Sobral; Isabel Albergaria; Gisela Gaspar; José M Ferro; Sofia A Oliveira; Astrid M Vicente
Journal:  BMC Med Genet       Date:  2010-03-11       Impact factor: 2.103

10.  Correlation between the -1562C/T polymorphism in the matrix metalloproteinase-9 gene and hemorrhagic transformation of ischemic stroke.

Authors:  Xiaoman Zhang; Xinhui Cao; Xiaoyu Xu; Aifan Li; Yuming Xu
Journal:  Exp Ther Med       Date:  2015-01-16       Impact factor: 2.447

View more
  12 in total

1.  Matrix metalloproteinase-9 gene polymorphisms and their interaction with environment on subarachnoid hemorrhage risk.

Authors:  Tao Wang; Wanxing Fu; Shuang Song; Yanlong Han; Lihong Yao; Youkui Lu; Junshuai Zheng; Jing Wang
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

2.  Polymorphisms of the matrix metalloproteinase genes are associated with essential hypertension in a Caucasian population of Central Russia.

Authors:  Maria Moskalenko; Irina Ponomarenko; Evgeny Reshetnikov; Volodymyr Dvornyk; Mikhail Churnosov
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

3.  Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack.

Authors:  Yoichi Yoshida; Hao Wang; Takaki Hiwasa; Toshio Machida; Eiichi Kobayashi; Seiichiro Mine; Go Tomiyoshi; Rika Nakamura; Natsuko Shinmen; Hideyuki Kuroda; Hirotaka Takizawa; Koichi Kashiwado; Ikuo Kamitsukasa; Hideo Shin; Takeshi Wada; Akiyo Aotsuka; Eiichiro Nishi; Mikiko Ohno; Minoru Takemoto; Koutaro Yokote; Sho Takahashi; Jun Matsushima; Xiao-Meng Zhang; Masaki Takiguchi; Yasuo Iwadate
Journal:  Oncotarget       Date:  2017-12-24

4.  Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.

Authors:  Hao Wang; Xiao-Meng Zhang; Go Tomiyoshi; Rika Nakamura; Natsuko Shinmen; Hideyuki Kuroda; Risa Kimura; Seiichiro Mine; Ikuo Kamitsukasa; Takeshi Wada; Akiyo Aotsuka; Yoichi Yoshida; Eiichi Kobayashi; Tomoo Matsutani; Yasuo Iwadate; Kazuo Sugimoto; Masahiro Mori; Akiyuki Uzawa; Mayumi Muto; Satoshi Kuwabara; Minoru Takemoto; Kazuki Kobayashi; Harukiyo Kawamura; Ryoichi Ishibashi; Koutaro Yokote; Mikiko Ohno; Po-Min Chen; Eiichiro Nishi; Koh Ono; Takeshi Kimura; Toshio Machida; Hirotaka Takizawa; Koichi Kashiwado; Hideaki Shimada; Masaaki Ito; Ken-Ichiro Goto; Katsuro Iwase; Hiromi Ashino; Akiko Taira; Emiko Arita; Masaki Takiguchi; Takaki Hiwasa
Journal:  Oncotarget       Date:  2017-12-31

Review 5.  Elevation of Autoantibody in Patients with Ischemic Stroke.

Authors:  Yoichi Yoshida; Takaki Hiwasa; Toshio Machida; Eiichi Kobayashi; Seiichiro Mine; Jun Matsushima; Masaki Takiguchi; Yasuo Iwadate
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-05-31       Impact factor: 1.742

6.  Association between Increased Matrix Metalloproteinase-9 (MMP-9) Levels with Hyperglycaemia Incidence in Acute Ischemic Stroke Patients.

Authors:  Ismail Setyopranoto; Rusdy Ghazali Malueka; Andre Stefanus Panggabean; I Putu Eka Widyadharma; Ahmad Hamim Sadewa; Rusdi Lamsudin; Samekto Wibowo
Journal:  Open Access Maced J Med Sci       Date:  2018-11-18

7.  Association of the matrix metalloproteinase-3 polymorphisms rs679620 and rs3025058 with ischemic stroke risk: a meta-analysis.

Authors:  Qi-Wei Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-01-31       Impact factor: 2.570

8.  The Effect of Naoxintong Capsule in the Treatment of Patients with Cerebral Infarction and Carotid Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Trials.

Authors:  Qiuer Liang; Yunfei Cai; Ruixue Chen; Weihao Chen; Liguo Chen; Ya Xiao
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-24       Impact factor: 2.629

9.  The association of polymorphisms in promoter region of MMP2 and MMP9 with recurrent spontaneous abortion risk in Chinese population.

Authors:  Li Li; Jia Liu; Shuang Qin; Ruiman Li
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

10.  Matrix metalloproteinase-2 gene polymorphisms are associated with ischemic stroke in a Hainan population.

Authors:  Fanglin Niu; Boping Wei; Mengdan Yan; Jing Li; Yongri Ouyang; Tianbo Jin
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.